S. Ratcliffe

发表

Heterologous prime/boost immunizations of rhesus monkeys using chimpanzee adenovirus vectors.

D. Montefiori, S. Santra, N. Letvin, 2009, Vaccine.

This information is current as Immunodeficiency Virus Disease Progression Replication but Do Not Protect from Simian T Cells Reduce Virus + Virus-Specific CD8 Vaccine-Induced, Simian Immunodeficiency

J. Altman, S. Staprans, M. Feinberg, 2017 .

Adenovirus vector-induced immune responses in nonhuman primates: responses to prime boost regimens

M. Betts, Z. Xiang, H. Ertl, 2009, The Journal of Immunology.

Hexon-modified recombinant E1-deleted adenovirus vectors as dual specificity vaccine carriers for influenza virus.

Z. Xiang, H. Ertl, Dongming Zhou, 2013, Molecular therapy : the journal of the American Society of Gene Therapy.

B cell responses to the 2011/12-influenza vaccine in the aged

Susan A. Doyle, K. Schmader, Z. Xiang, 2013, Aging.

Vaccination with Ad5 Vectors Expands Ad5-Specific CD8+ T Cells without Altering Memory Phenotype or Functionality

M. Betts, H. Ertl, D. Carnathan, 2010, PloS one.

Mother-to-Infant Transmission of Simian Immunodeficiency Virus Is Rare in Sooty Mangabeys and Is Associated with Low Viremia

G. Silvestri, A. Chahroudi, B. Lawson, 2011, Journal of Virology.

Mother-to-Infant Transmission of Simian Immunodeﬁciency Virus Is Rare in Sooty Mangabeys and Is Associated with Low Viremia (cid:1)

G. Silvestri, A. Chahroudi, J. Else, 2011 .

Cooperation Between Systemic IgG1 and Mucosal Dimeric IgA2 Monoclonal Anti-HIV Env Antibodies: Passive Immunization Protects Indian Rhesus Macaques Against Mucosal SHIV Challenges

A. Lanzavecchia, E. Cameroni, D. Corti, 2021, Frontiers in Immunology.

Correlates of relative resistance against low‐dose rectal simian immunodeficiency virus challenges in peripheral blood mononuclear cells of vaccinated rhesus macaques

D. Carnathan, G. Silvestri, A. Kossenkov, 2013, Journal of leukocyte biology.

IL-13 is a driver of COVID-19 severity

R. Preissner, P. Bourne, G. Buck, 2021, JCI insight.

Adenovirus Vector-Induced Immune Responses in Nonhuman Primates: Responses to Prime Boost Regimens1

M. Betts, Z. Xiang, H. Ertl, 2009, The Journal of Immunology.

A Five-Year Longitudinal Analysis of Sooty Mangabeys Naturally Infected with Simian Immunodeficiency Virus Reveals a Slow but Progressive Decline in CD4+ T-Cell Count Whose Magnitude Is Not Predicted by Viral Load or Immune Activation

G. Silvestri, M. Paiardini, J. Taaffe, 2010, Journal of Virology.

Vaccine-Induced, Simian Immunodeficiency Virus-Specific CD8+ T Cells Reduce Virus Replication but Do Not Protect from Simian Immunodeficiency Virus Disease Progression1

J. Altman, S. Staprans, M. Feinberg, 2009, The Journal of Immunology.

Baseline Ad5 serostatus does not predict Ad5-HIV vaccine-induced expansion of Ad-specific CD4+ T-cells

M. Betts, H. Ertl, D. Carnathan, 2009, Nature Medicine.

Temporal Dynamics of CD8+ T Cell Effector Responses during Primary HIV Infection

B. Haynes, A. McMichael, M. Betts, 2016, PLoS pathogens.

Acquired epidermodysplasia verruciformis syndrome in HIV-infected pediatric patients: prospective treatment trial with topical glycolic acid and human papillomavirus genotype characterization.

C. Kovarik, S. Tyring, Ivy Lee, 2012, Archives of dermatology.

Depletion of CD4⁺ T cells abrogates post-peak decline of viremia in SIV-infected rhesus macaques.

J. Brenchley, G. Silvestri, M. Paiardini, 2011, The Journal of clinical investigation.

Mucosal AIDS virus transmission is enhanced by antiviral IgG isolated early in infection

R. Ruprecht, S. Ratcliffe, S. Lakhashe, 2021, AIDS.

Vaccine-induced T cells provide partial protection against high-dose rectal SIVmac239 challenge of rhesus macaques.

J. Brenchley, M. Betts, Z. Xiang, 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

Title Passive immunization of macaques with polyclonal anti-SHIV IgG against a heterologous tier 2 SHIV : outcome depends on IgG dose Permalink

D. Montefiori, H. Ertl, M. Robert-Guroff, 2014 .

Passive immunization of macaques with polyclonal anti-SHIV IgG against a heterologous tier 2 SHIV: outcome depends on IgG dose

D. Montefiori, H. Ertl, M. Robert-Guroff, 2014, Retrovirology.

Impact of Human Immunodeficiency Virus Infection on Survival and Acute Toxicities From Chemoradiation Therapy for Cervical Cancer Patients in a Limited-Resource Setting.

S. Dryden-Peterson, S. Grover, A. Viswanathan, 2018, International journal of radiation oncology, biology, physics.

The fourth author's name was omitted from the article. The corrected author and affiliation lines are shown below.

M. Betts, Z. Xiang, H. Ertl, 2009 .

Immunological and Virological Analyses of Rhesus Macaques Immunized with Chimpanzee Adenoviruses Expressing the Simian Immunodeficiency Virus Gag/Tat Fusion Protein and Challenged Intrarectally with Repeated Low Doses of SIVmac

H. Ertl, D. Carnathan, G. Silvestri, 2013, Journal of Virology.

Effect of preexisting immunity to adenovirus on transgene product-specific genital T cell responses on vaccination of mice with a homologous vector.

H. Ertl, S. Ratcliffe, L. Haut, 2011, The Journal of infectious diseases.

Availability of activated CD4+ T cells dictates the level of viremia in naturally SIV-infected sooty mangabeys.

A. Haase, S. Staprans, K. Reimann, 2008, The Journal of clinical investigation.

Increased Mucosal CD4+ T Cell Activation in Rhesus Macaques following Vaccination with an Adenoviral Vector

M. Betts, James M. Wilson, S. Bellamy, 2014, Journal of Virology.

CCR5 blockade is well tolerated and induces changes in the tissue distribution of CCR5+ and CD25+ T cells in healthy, SIV‐uninfected rhesus macaques

G. Silvestri, M. Paiardini, S. Bosinger, 2012, Journal of medical primatology.

Lack of Atorvastatin Effect on Monocyte Gene Expression and Inflammatory Markers in HIV-1-infected ART-suppressed Individuals at Risk of non-AIDS Comorbidities

L. Montaner, P. Shaw, P. Tebas, 2021, Pathogens & immunity.

Corrigendum: Baseline Ad5 serostatus does not predict Ad5 HIV vaccine–induced expansion of adenovirus-specific CD4+ T cells